Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Ovarian Neoplasms 14 Fallopian Tube Neoplasms 12 Breast Neoplasms 8 Prostatic Neoplasms 7 Neoplasms 7 Carcinoma, Ovarian Epithelial 6 Endometrial Neoplasms 5 Pancreatic Neoplasms 4 Uterine Cervical Neoplasms 3 Recurrence 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Solid Tumor 2 Small Cell Lung Carcinoma 2 Neoplasm Metastasis 2 Metastatic Castration Resistant Prostate Cancer 2 Lung Neoplasms 2 Leiomyosarcoma 2 Carcinoma, Transitional Cell 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Solid Tumor, Unspecified, Adult 1 Sarcoma 1 Prostate Cancer Metastatic 1 Primary Myelofibrosis 1 Pathologic Complete Response 1 Myeloproliferative Disorders 1

Interventions

Cisplatin 57 Pemetrexed 45 pembrolizumab 18 Nivolumab 15 Carboplatin 15 Gemcitabine 14 Cyclophosphamide 13 Radiotherapy 10 atezolizumab 8 Drug Therapy 8 Platinum 7 Ipilimumab 7 Doxorubicin 7 durvalumab 6 1,2-diaminocyclohexaneplatinum II citrate 6 tremelimumab 5 sodium thiosulfate 5 Vinorelbine 5 Radiotherapy, Intensity-Modulated 5 Interleukin-2 5 Chemotherapy, Adjuvant 5 Cerebral Decortication 5 sargramostim 4 fludarabine 4 defactinib 4 aldesleukin 4 tumor necrosis factor-alpha, CNGRC fusion protein, human 3 cediranib 3 Photochemotherapy 3 Neoadjuvant Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mesothelioma, Malignant × rucaparib × Clear all

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡